Carroucell
Whatever the adherent cell, whatever the culture environment, we have the microcarrier solution, in R&D and GMP grade!
Whatever the adherent cell, whatever the culture environment, we have the microcarrier solution, in R&D and GMP grade!
Carroucell is a biotechnology startup that positions itself as the microcarrier supplier for cell culture in bioreactors. With a foundation year of 2016, the company has recently attracted substantial attention in the investment landscape. In its latest financing round, Carroucell secured a noteworthy €1.50M Series A investment on 07 September 2022. The investment was led by prominent backers including Bpifrance, Crédit Agricole, and Novalis Biotech. This latest investment indicates a strong show of confidence from reputable investors in the promising potential of Carroucell's innovative solutions for cell culture in bioreactors. Considering the recent support from key players in the investment domain, Carroucell is well-positioned to capitalize on the burgeoning opportunities in the biotechnology space.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | €1.50M | 3 |
|
07 Sep 2022 |
No recent news or press coverage available for Carroucell.
We care about your data, and we'd love to use cookies make your experience better.